Woerle Hans-Juergen 4
4 · Seres Therapeutics, Inc. · Filed Feb 6, 2025
Insider Transaction Report
Form 4
Woerle Hans-Juergen
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-04+120,000→ 120,000 totalExercise: $0.81Exp: 2035-02-03→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option will vest in four substantially equal installments on each anniversary of February 4, 2025 or in full immediately prior to the occurrence of a change in control.